Sign in
FB

Franklin BSP Realty Trust, Inc. (FBRT)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 2025 was operationally steady: GAAP net income was $24.4M, diluted EPS to common was $0.19, fully converted GAAP EPS was $0.21, and Distributable Earnings were $29.0M ($0.27 per fully converted share), supported by $4.5B core portfolio, $501M liquidity, and net leverage of 2.24x .
  • Management outlined a clear path to full dividend coverage via three drivers: calling amortizing CLOs, reinvesting equity tied up in REO/workouts, and integrating NewPoint (targeting ~8%+ ROE), implying pro forma DE EPS of $0.38–$0.48 and 107–135% coverage over time .
  • Portfolio quality indicators remained favorable: 74% multifamily, 99% senior, average risk rating 2.3; watch list loans edged to eight (one 5-rated, seven 4-rated), and REO sales continued (three assets sold at ~$56M during the quarter) .
  • Stock catalyst: management emphasized valuation discount vs book value ($14.82 fully converted) and argued implied losses far exceed realistic outcomes given payoffs at par and REO sales above basis; NewPoint adds capital-light earnings durability and BVPS accretion potential .

What Went Well and What Went Wrong

What Went Well

  • “We continue to make meaningful progress across our legacy portfolio and see a clear path to dividend coverage,” supported by DE of $29.0M ($0.27 fully converted), positive credit loss benefit (+$1.5M), and liquidity of $500.6M .
  • NewPoint closed July 1, with 2025 guidance of $4.0–$4.5B Agency/FHA volume, GAAP net income $23–$27M, and DE $13–$17M; MSR value ~$217M (6.8yr life) positions FBRT for growing, capital-light earnings and BV accretion .
  • REO resolutions: sold three assets for $56M in Q2; over two years, ten REOs sold for ~$270M aggregate at UPB at time of transfer, reinforcing recovery strategy and supporting the narrative of manageable legacy risk .

What Went Wrong

  • Earned asset yields compressed amid “deluge of liquidity” and tight spreads; originations were deliberately lower (new commitments $60.8M) with management avoiding “chasing to the tightest levels” .
  • Dividend coverage remains below 100% near-term (DE coverage 76% in Q2), reflecting under-earning REO/non-performing assets and timing to redeploy equity; management reiterated path but acknowledged timing uncertainty .
  • Debt cost drifted higher: average debt cost incl. financing rose to 7.1% from 6.9% in Q1; several CLOs beyond reinvestment period reduced advance rates, necessitating calls to re-optimize leverage .

Financial Results

Core P&L and Earnings versus prior year and prior quarter

MetricQ2 2024Q1 2025Q2 2025
Total Income ($USD Millions)$50.885$50.112 $49.294
Net Interest Income ($USD Millions)$46.813$43.315 $40.958
Revenue from REO ($USD Millions)$4.072$6.797 $8.336
GAAP Net Income ($USD Millions)$(3.765)$23.705 $24.384
Diluted EPS to common ($USD)$(0.11)$0.20 $0.19
GAAP EPS – fully converted ($USD)$(0.08) $0.22 $0.21
Distributable Earnings ($USD Millions)$32.353 $(6.234) $29.005
DE per share – fully converted ($USD)$0.31 $(0.12) $0.27
GAAP ROE (%)(2.0)% 5.7% 5.5%
DE ROE (%)8.0% (3.3)% 7.3%
Dividend per share ($USD)$0.355 $0.355 $0.355

Results vs Wall Street consensus (S&P Global)

Metric (Q2 2025)ConsensusActualResult
Primary EPS ($)0.30*0.27*Miss
Revenue ($USD Millions)55.77*55.75*In-line

Values retrieved from S&P Global.*

Segment and Portfolio Breakdown (Q2 2025)

KPIValue
Core Portfolio Principal Balance$4.5B
Loans / Avg Size145 loans; $31M avg UPB
Senior vs Mezzanine99% Senior; 1% Mezzanine
Rate Type88% Floating; 12% Fixed
Collateral Mix74% Multifamily; 14% Hospitality; 6% Industrial; 3% Office; 1% Retail; 2% Other
Regional MixSoutheast 43%; Southwest 35%; others diversified
Watch List8 loans (1 RR5, 7 RR4)
Non-performing loans2 positions
Foreclosure REO10 positions; $246M book value
Liquidity$500.6M total; $76.8M cash
Net Leverage / Recourse Net Leverage2.24x / 0.32x
Book Value per share (fully converted)$14.82
Average debt cost (incl. financing)7.1% (vs 6.9% in Q1)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Dividend per shareQ2 2025$0.355$0.355Maintained
Distributable EPS (Pro Forma Path to Coverage)Pro FormaN/A$0.38–$0.48; coverage 107%–135%New disclosure
NewPoint Agency/FHA VolumeFY 2025N/A$4.0–$4.5BNew disclosure
NewPoint GAAP Net IncomeFY 2025N/A$23–$27MNew disclosure
NewPoint Distributable EarningsFY 2025N/A$13–$17MNew disclosure
NewPoint Accretion TimingGAAP BVPS/GAAP EPSN/AAccretive 1H 2026 (GAAP/BVPS); DE accretive 2H 2026New disclosure

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 2024 and Q1 2025)Current Period (Q2 2025)Trend
Dividend coverage pathQ4: REO drag; $0.25–$0.30 annual DE potential from REO redeploy ; Q1: coverage near-term below 100%, monitor REO timing Three drivers (CLO calls, REO redeploy, NewPoint ~8% ROE) to reach coverage; pro forma $0.38–$0.48 DE EPS Improving
Originations and spreadsQ4: ~$2B 2024 originations; spreads tightened 25–50 bps vs cycle peaks ; Q1: paused originations ahead of NewPoint closing; tight spreads Q2: selectively originated $61M; spreads meaningfully tighter (100–125 bps vs a year ago; 25–50 bps vs 60–90 days ago) Mixed (opportunity but tighter pricing)
REO resolutionsQ4: 4 REOs sold near basis; active pipeline for sales ; Q1: further sales and LOIs; focus on fast redeploy Q2: 3 assets sold for ~$56M; cumulative 10 properties sold ~$270M; remaining REO progressing to stabilization/sale Improving
Office exposureQ4: traditional multi-tenant office ~2.3% of portfolio; heavy markdowns ; Q1: Denver office to REO; leave GA office as RR5 Q2: adjusted office exposure ~$105M; added Phoenix office to watch list; net lease HQ loan expected full payoff at maturity De-risking
NewPoint integrationQ1: approvals on track; strategic fit highlighted ;Q2: closed; 2025 guidance; MSR $217M; servicing migration underway; accretive timeline articulated Positive
Liquidity/leverageQ4: liquidity $535M; plan to return to CLO market ; Q1: liquidity $913M pre-closing Q2: liquidity $501M; net leverage 2.24x; plan to call amortized CLOs and re-lever assets Normalizing post-closing
Interest rate floorsQ4/Q1: rate floors on recent originations favorable if SOFR declines ;Q2: reiterates benefit from falling rates due to floors; EPS sensitivity table shows positive correlation Supportive tailwind
Valuation/stock discountQ1: long-term potential to trade above BV with agency focus ;Q2: discount implies ~$450M losses; mgmt views scenario “highly unlikely,” citing payoffs and REO sales above basis Potential re-rating catalyst

Management Commentary

  • “We continue to make meaningful progress across our legacy portfolio and see a clear path to dividend coverage. With the NewPoint acquisition now closed, FBRT is uniquely positioned to grow and create long-term value for stockholders.” — Michael Comparato, President .
  • “There are collective incremental distributable earnings of $0.16–$0.26 per share per quarter” from CLO calls, REO redeploy, and NewPoint scaling; pro forma coverage 107–135% .
  • “Our stock continues to trade at a steep discount to book value… for our book value to match the current stock price, we would need to recognize approximately $450 million in additional loan losses… highly unlikely.” — Michael Comparato .
  • “We expect NewPoint to be accretive from a GAAP earnings and book value per share standpoint in the first half of 2026, and accretive to distributable earnings in the second half of 2026.” — Jerome Baglien (CFO/COO) .

Q&A Highlights

  • Originations resuming post-NewPoint; target core portfolio size around ~$5B to support dividend coverage; expect quarter-over-quarter ramp .
  • Spreads materially tighter versus last year (100–125 bps) and versus 60–90 days ago (25–50 bps); management remains selective to avoid lowest pricing .
  • CLO strategy: call amortizing deals (e.g., FL6/FL7/FL9) to re-level advances (~75%) and free equity for originations; net leverage target range ~2.5–2.75x .
  • NewPoint pro forma and modeling: 2025 GAAP $23–$27M and DE $13–$17M; servicing migration of BSP loans drives multi-million savings and float benefits; accretion timelines reiterated .
  • Regulatory backdrop: mgmt sees continued government commitment to housing liquidity; agency channel expected to remain lowest cost-of-capital and in demand .

Estimates Context

  • Q2 2025 EPS missed S&P Global consensus (0.27 vs 0.30); revenue was in line ($55.75M vs $55.77M). Target price consensus stood at ~$$14.38 [GetEstimates].
  • Near-term estimate revisions may modestly reflect spread compression and under-earning REO drag; medium-term estimates likely to incorporate incremental DE from CLO calls, REO redeploy, and NewPoint integration as visibility improves .

Values retrieved from S&P Global.*

Key Takeaways for Investors

  • The quarter was stable with DE recovery and positive credit loss benefit; liquidity post-NewPoint remains ample to re-accelerate originations without chasing tight spreads .
  • Dividend appears sustainable medium term given three concrete drivers to coverage; watch for CLO call execution and REO sale cadence as catalysts for DE uplift .
  • Portfolio risk looks contained: heavy multifamily mix, low office exposure, strong watch-list engagement, and demonstrated REO recoveries at or above basis; this supports management’s challenge of market-implied loss severity .
  • NewPoint is a strategic pivot to capital-light earnings with MSR accretion and servicing synergies; monitor Agency/FHA volumes and servicing migration milestones through 2026 .
  • Tactical trade: potential re-rating toward BV as execution reduces perceived legacy risk; near-term stock moves may correlate with announced CLO calls, REO sale closings, and originations ramp .
  • Balance-sheet flexibility: 79% non-mark-to-market financing on core book and manageable recourse leverage (0.32x) limit forced deleveraging risk in volatile markets .
  • Rate path sensitivity skew: earnings benefit from falling SOFR due to index floors on recent originations; downside from rate declines is mitigated relative to peers .

Other Relevant Q2 2025 Press Releases and Prior Quarter Reference

  • Issued $107M unsecured notes (8.25% due 2030; FRNs due 2028 at ~8.33%) to support general purposes including NewPoint purchase funding, strengthening liability flexibility .
  • Q1 2025: GAAP net income $23.7M, diluted EPS $0.20; DE $(6.2)M due to realized losses; liquidity $912.8M pre-NewPoint closing; book value $14.95 fully converted .
  • Q4 2024 context: GAAP diluted EPS $0.29; DE $0.30; strong origination activity and continued paydowns; office exposure trimmed further .